Is antioxidant use protective of cognitive function in the community-dwelling elderly? - PubMed (original) (raw)
Comparative Study
Is antioxidant use protective of cognitive function in the community-dwelling elderly?
Shelly L Gray et al. Am J Geriatr Pharmacother. 2003 Sep.
Abstract
Background: The role of oxidative stress in the pathogenesis of diseases such as macular degeneration, certain types of cancer, and Alzheimer's disease has received much attention. Thus, there is considerable interest in the potential contribution of antioxidants to the prevention of these diseases.
Objective: The objective of this study was to determine whether use of supplemental antioxidants (vitamins A, C, or E, plus selenium or zinc) was associated with a reduced risk of development of cognitive impairment or cognitive decline in a representative sample of the community-dwelling elderly.
Methods: The sample consisted of 2082 nonproxy subjects from the Duke Established Populations for Epidemiologic Studies of the Elderly who were not cognitively impaired at the 1989-1990 interview (baseline for the present analysis). Medication use was determined during in-home interviews. Cognitive function was assessed 3 and 7 years from baseline in terms of incident cognitive impairment, as measured on the Short Portable Mental Status Questionnaire (SPMSQ) using specific cut points (number of errors) based on race and education, and cognitive decline, defined as an increase of > or = 2 errors on the SPMSQ. Multivariate analyses were performed using weighted data adjusted for sampling design and controlled for sociodemographic characteristics, health-related behaviors, and health status.
Results: At baseline, 224 (10.8%) subjects were currently taking a supplement containing an antioxidant. During the follow-up period, 24.0% of subjects developed cognitive impairment and 34.5% experienced cognitive decline. Current antioxidant users had a 34.0% lower risk of developing cognitive impairment compared with non-antioxidant users (adjusted relative risk [RR], 0.66; 95% CI, 0.44-1.00) and a 29.0% lower risk of experiencing cognitive decline (adjusted RR, 0.71; 95% CI, 0.49-1.01).
Conclusion: The results of this analysis suggest a possible beneficial effect of antioxidant use in terms of reducing cognitive decline among the community-dwelling elderly.
Similar articles
- Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly.
Hanlon JT, Landerman LR, Artz MB, Gray SL, Fillenbaum GG, Schmader KE. Hanlon JT, et al. Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):781-7. doi: 10.1002/pds.952. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386717 - Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia.
Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. Maxwell CJ, et al. Dement Geriatr Cogn Disord. 2005;20(1):45-51. doi: 10.1159/000085074. Epub 2005 Apr 12. Dement Geriatr Cogn Disord. 2005. PMID: 15832036 - Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline.
Basambombo LL, Carmichael PH, Côté S, Laurin D. Basambombo LL, et al. Ann Pharmacother. 2017 Feb;51(2):118-124. doi: 10.1177/1060028016673072. Epub 2016 Oct 5. Ann Pharmacother. 2017. PMID: 27708183 - Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies.
Rafnsson SB, Dilis V, Trichopoulou A. Rafnsson SB, et al. Eur J Nutr. 2013 Sep;52(6):1553-67. doi: 10.1007/s00394-013-0541-7. Epub 2013 Jun 7. Eur J Nutr. 2013. PMID: 23744025 Review. - Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Bjelakovic G, et al. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007176. doi: 10.1002/14651858.CD007176. Cochrane Database Syst Rev. 2008. PMID: 18425980 Updated. Review.
Cited by
- Correlation between antibutyrylcholinesterasic and antioxidant activities of three aqueous extracts from Tunisian Rhus pentaphyllum.
Ben Mansour H, Yatouji S, Mbarek S, Houas I, Delai A, Dridi D. Ben Mansour H, et al. Ann Clin Microbiol Antimicrob. 2011 Aug 31;10:32. doi: 10.1186/1476-0711-10-32. Ann Clin Microbiol Antimicrob. 2011. PMID: 21880140 Free PMC article. - Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study.
Lam PK, Kritz-Silverstein D, Barrett Connor E, Milne D, Nielsen F, Gamst A, Morton D, Wingard D. Lam PK, et al. J Nutr Health Aging. 2008 Jan;12(1):22-7. doi: 10.1007/BF02982160. J Nutr Health Aging. 2008. PMID: 18165841 Free PMC article. - Effects of exercise interventions in Alzheimer's disease: A meta-analysis.
Roy SK, Wang JJ, Xu YM. Roy SK, et al. Brain Behav. 2023 Jul;13(7):e3051. doi: 10.1002/brb3.3051. Epub 2023 Jun 18. Brain Behav. 2023. PMID: 37334441 Free PMC article. - Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.
Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J. Akuffo KO, et al. Ophthalmic Epidemiol. 2014 Apr;21(2):111-23. doi: 10.3109/09286586.2014.888085. Ophthalmic Epidemiol. 2014. PMID: 24621122 Free PMC article. Clinical Trial. - Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults.
Beydoun MA, Fanelli-Kuczmarski MT, Kitner-Triolo MH, Beydoun HA, Kaufman JS, Mason MA, Evans MK, Zonderman AB. Beydoun MA, et al. Psychosom Med. 2015 Jan;77(1):68-82. doi: 10.1097/PSY.0000000000000129. Psychosom Med. 2015. PMID: 25478706 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical